Recruiting A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity NCT06406465 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
